Trading · Founded 1993 · www.elegantflora.in · BSE 526473 · · ISIN INE152E01013
No Notes Added Yet
Business
Elegant Floriculture & Agrotech (India) Ltd. operates in the Trading sector. Its core business involves buying and selling goods, primarily those related to floriculture (cultivation of flowering and ornamental plants) and agrotech (agricultural technology or products). The company acts as an intermediary, sourcing products from producers or suppliers and distributing them to buyers or consumers. It generates revenue by earning a margin on the difference between the purchase price and the sale price of the goods it trades.
Revenue Mix
Given the company name, its trading activities are expected to primarily revolve around products and materials pertinent to floriculture and agricultural technology. Without specific financial reporting, a detailed breakdown of major business segments or their contribution to revenue (e.g., specific types of floricultural products vs. agrotech equipment/materials) is not available.
Industry
The company operates in the Trading industry within India, likely focusing on agricultural and horticultural commodities or related inputs. The trading industry, especially for agricultural products, can be fragmented, characterized by numerous local and regional players, along with larger national distributors. Competition is often driven by price, sourcing efficiency, logistics capabilities, and market access. Without specific market share data or financial metrics, the company's precise positioning relative to peers cannot be determined, but it likely competes on its ability to efficiently source and distribute specialized floriculture and agrotech products.
MOAT
Trading companies typically possess weaker moats compared to asset-heavy or brand-driven businesses. Durable competitive advantages (moats) in the trading sector generally stem from exclusive sourcing agreements, extensive and efficient distribution networks, deep market expertise, strong financial capacity to manage inventory and credit, or significant scale. Based on the available general information, specific durable competitive advantages for Elegant Floriculture & Agrotech (India) Ltd. are not evident. Its competitive edge would likely depend on operational efficiency, relationships with suppliers and customers, and market knowledge.
Growth Drivers
Key factors that could drive the company's growth over the next 3-5 years include:
Increasing demand: Growing disposable incomes and urbanization in India can lead to higher demand for floricultural products and advanced agricultural inputs.
Expansion of network: Enhancing sourcing capabilities and expanding distribution channels across new geographies or customer segments.
Product diversification: Adding new, high-margin floriculture or agrotech products to its trading portfolio.
Technological adoption: Leveraging technology for supply chain optimization, inventory management, and market intelligence.
Government support: Favorable government policies and incentives for agriculture and horticulture sectors in India.
Risks
Commodity price volatility: If the company trades agricultural commodities, fluctuations in their prices can impact margins and profitability.
Supply chain disruptions: Issues such as adverse weather, pest outbreaks, logistics challenges, or political instability can disrupt supply.
Competition: Intense competition from existing traders and new entrants can put pressure on trading margins.
Inventory management: Risks associated with spoilage, obsolescence, or carrying costs, particularly for perishable floricultural items.
Credit risk: Risk of non-payment or delayed payment from customers.
Regulatory changes: Changes in agricultural policies, trade tariffs, or import/export regulations.
Management & Ownership
As an Indian company, Elegant Floriculture & Agrotech (India) Ltd. is likely promoter-driven, a common structure in the country. Without specific details on the promoters' background, experience, or shareholding, or information about the board of directors and management team, it is not possible to assess management quality or describe the specific ownership structure.
Outlook
The outlook for Elegant Floriculture & Agrotech (India) Ltd. presents a balanced view. On the positive side, India's growing economy, increasing focus on agriculture, and expanding demand for floriculture products could provide a conducive environment for growth. Efficient sourcing, strong distribution capabilities, and strategic product diversification could allow the company to capitalize on these trends, leading to higher trading volumes and improved profitability. However, the company faces inherent challenges typical of a trading business, including exposure to commodity price volatility, intense competition, and potential supply chain disruptions. Effective risk management, robust operational efficiency, and the ability to adapt to changing market dynamics will be crucial for sustained performance.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 1 | 0 | 15 | 10 | 0 | 0 | 3 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 0 | 0 | 0 | 1 | 1 | 15 | 10 | 0 | 0 | 3 |
| Total Expenditure | 0 | 0 | 0 | 0 | 0 | 15 | 9 | 0 | 0 | 2 |
| Operating Profit | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -0 | 0 |
| Provision for Tax | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -0 | 0 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Profit After Adjustments | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -0 | 0 |
| Adjusted Earnings Per Share | 0.1 | 0.1 | 0 | 0.4 | 0.1 | 0.1 | 0.1 | 0 | -0 | 0.1 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 13 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 |
| Total Income | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 3 | 13 |
| Total Expenditure | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 11 |
| Operating Profit | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 2 | 0 |
| Interest | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 1 | 0 | 0 | 0 | -0 | 0 | -0 | -0 | 1 | 0 |
| Provision for Tax | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 |
| Profit After Tax | 0 | 0 | 1 | 0 | -0 | -0 | -0 | 0 | -0 | 0 | 1 | 0 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 0 | 0 | 1 | 0 | -0 | -0 | -0 | 0 | -0 | 0 | 1 | 0 |
| Adjusted Earnings Per Share | 0.1 | 0 | 0.5 | 0 | -0.1 | -0.1 | -0.2 | 0.1 | -0.1 | 0 | 0.6 | 0.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | 0% | 0% | 0% |
| Operating Profit CAGR | 0% | 26% | 15% | 7% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -18% | -11% | 11% | -0% |
| ROE Average | 5% | 2% | 1% | 1% |
| ROCE Average | 6% | 2% | 1% | 1% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 20 | 20 | 22 | 22 | 21 | 21 | 21 | 21 | 21 | 21 | 24 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 0 | 5 | 0 | 6 | 6 | 0 | 0 | 0 | 0 | 0 | 9 |
| Total Liabilities | 22 | 27 | 23 | 28 | 28 | 22 | 22 | 22 | 21 | 22 | 33 |
| Fixed Assets | 3 | 3 | 4 | 4 | 3 | 3 | 2 | 2 | 2 | 1 | 1 |
| Other Non-Current Assets | 13 | 12 | 12 | 10 | 10 | 14 | 13 | 4 | 3 | 3 | 3 |
| Total Current Assets | 6 | 11 | 7 | 14 | 15 | 6 | 6 | 16 | 17 | 17 | 29 |
| Total Assets | 22 | 27 | 23 | 28 | 28 | 22 | 22 | 22 | 21 | 22 | 33 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | -0 | -5 | 1 | -2 | 0 | 3 | -1 | -10 | -1 | -1 | -2 |
| Cash Flow from Investing Activities | -0 | 0 | -1 | 2 | 0 | -3 | 1 | 10 | 1 | 1 | 1 |
| Cash Flow from Financing Activities | 1 | 5 | 0 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net Cash Inflow / Outflow | 0 | 0 | 1 | -0 | 0 | -0 | -0 | -0 | 0 | -0 | -1 |
| Closing Cash & Cash Equivalent | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -1 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.12 | 0.01 | 0.46 | 0.02 | -0.05 | -0.06 | -0.23 | 0.07 | -0.06 | 0.01 | 0.58 |
| CEPS(Rs) | 0.3 | 0.2 | 0.68 | 0.23 | 0.17 | 0.16 | -0.01 | 0.28 | 0.16 | 0.23 | 0.77 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 10.15 | 10.16 | 10.8 | 10.82 | 10.77 | 10.7 | 10.48 | 10.55 | 10.48 | 10.49 | 11.07 |
| Core EBITDA Margin(%) | 26.56 | 23.02 | 23.9 | 19.07 | 6.93 | -2.76 | -10.21 | -10.59 | -32.05 | -20.19 | 32.87 |
| EBIT Margin(%) | 18.88 | 7.23 | 24.81 | 18.49 | 6.59 | 14.18 | -6.55 | 31.91 | -21.86 | -3.33 | 118.8 |
| Pre Tax Margin(%) | 12.48 | 0.98 | 26.55 | 10.81 | 1.2 | 5.3 | -19.62 | 25.19 | -22.51 | -3.53 | 113.1 |
| PAT Margin (%) | 17.78 | 1.14 | 46.97 | 2.66 | -6.08 | -12.58 | -84.62 | 18.32 | -16.03 | 4.94 | 89.56 |
| Cash Profit Margin (%) | 45.17 | 25.29 | 69.05 | 37.49 | 20.11 | 31.51 | -3.73 | 74.81 | 39.74 | 77.2 | 118.55 |
| ROA(%) | 1.09 | 0.07 | 3.72 | 0.13 | -0.36 | -0.49 | -2.03 | 0.64 | -0.58 | 0.14 | 4.26 |
| ROE(%) | 1.15 | 0.09 | 4.41 | 0.15 | -0.47 | -0.59 | -2.14 | 0.66 | -0.59 | 0.14 | 5.39 |
| ROCE(%) | 1.19 | 0.47 | 2 | 0.92 | 0.4 | 0.56 | -0.16 | 1.14 | -0.81 | -0.1 | 5.88 |
| Receivable days | 55.86 | 53.87 | 46.36 | 78.55 | 68.22 | 110.96 | 130.05 | 89.27 | 87.69 | 102.37 | 53.1 |
| Inventory Days | 150.85 | 69.98 | 12.17 | 19.1 | 14.29 | 23.97 | 44.62 | 0 | 6.47 | 8.38 | 0 |
| Payable days | 387.59 | 70.92 | 2175.44 | 3366.38 | 1217.33 | 652.09 | 2178.44 | 555.24 | -728.63 | 0 | 0 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 627.87 | 0 | 391.28 | 8.89 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0.61 | 0.19 | 4.14 | 0.59 | 0.56 | 0.47 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 15.91 | 16.63 | 10.41 | 20.58 | 15.61 | 13.23 | 7.97 | 114.9 | 15.44 | 19.2 | 13.93 |
| EV/Core EBITDA(x) | 34.38 | 53 | 22.2 | 39.91 | 47.61 | 22.7 | 10.72 | 129.98 | 45.55 | 27.86 | 9.42 |
| Net Sales Growth(%) | 34.95 | 18.02 | 27.4 | -36.26 | 33.62 | -40.37 | -46.29 | 41.71 | 2.71 | -22.83 | 115.3 |
| EBIT Growth(%) | 40.78 | -54.83 | 337.36 | -52.52 | -52.35 | 28.23 | -124.82 | 790.44 | -170.37 | 88.25 | 7780.81 |
| PAT Growth(%) | 159.79 | -92.4 | 5126.13 | -96.4 | -406.07 | -23.37 | -261.13 | 130.68 | -189.86 | 123.77 | 3805.06 |
| EPS Growth(%) | 159.6 | -92.43 | 5146.59 | -96.4 | -405.97 | -23.38 | -261.15 | 130.69 | -189.8 | 123.84 | 3796.64 |
| Debt/Equity(x) | 0.04 | 0.29 | 0.05 | 0.28 | 0.31 | 0.03 | 0.02 | 0 | 0 | 0 | 0.35 |
| Current Ratio(x) | 30.35 | 2.28 | 21.83 | 2.5 | 2.38 | 16.53 | 13.75 | 69.45 | 127.74 | 128.76 | 3.18 |
| Quick Ratio(x) | 27.76 | 2.27 | 21.63 | 2.49 | 2.37 | 16.35 | 13.61 | 69.45 | 127.64 | 128.65 | 3.18 |
| Interest Cover(x) | 2.95 | 1.16 | -14.27 | 2.41 | 1.22 | 1.6 | -0.5 | 4.74 | -33.85 | -17 | 20.85 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0.05 | 0.1 | 0 | 0 | 0 | 0.75 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.55 | 7.55 | 7.55 | 7.55 | 0 | 0 | 0 | 0 | 0 | 0 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.17 |
| Public | 92.25 | 92.25 | 92.25 | 92.25 | 99.81 | 99.81 | 99.81 | 99.81 | 99.81 | 99.83 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.15 | 0.15 | 0.15 | 0.15 | 0 | 0 | 0 | 0 | 0 | 0 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 1.85 | 1.85 | 1.85 | 1.85 | 2 | 2 | 2 | 2 | 2 | 2.29 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2.29 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | 0% | 0% | 0% |
| Operating Profit CAGR | — | +26% | +15% | +7% |
| PAT CAGR | — | — | — | — |
| Share Price CAGR | -18% | -11% | +11% | 0% |
| ROE Average | +5% | +2% | +1% | +1% |
| ROCE Average | +6% | +2% | +1% | +1% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.55 | 7.55 | 7.55 | 7.55 | 0 | 0 | 0 | 0 | 0 | 0 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.17 |
| Public | 92.25 | 92.25 | 92.25 | 92.25 | 99.81 | 99.81 | 99.81 | 99.81 | 99.81 | 99.83 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.15 | 0.15 | 0.15 | 0.15 | 0 | 0 | 0 | 0 | 0 | 0 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 1.85 | 1.85 | 1.85 | 1.85 | 2 | 2 | 2 | 2 | 2 | 2.29 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2.29 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.